Effect of TGF‐β on differentiated organoids of the colon carcinoma cell line LIM 1863

[1]  M. Horton,et al.  Apoptosis induced by inhibition of intercellular contact , 1994, The Journal of cell biology.

[2]  A. Mantovani,et al.  A novel mechanism of colon carcinoma cell adhesion to the endothelium triggered by beta 1 integrin chain. , 1994, The Journal of biological chemistry.

[3]  R. Derynck,et al.  Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. , 1993, Science.

[4]  J. Gamble,et al.  Regulation of in vitro capillary tube formation by anti-integrin antibodies , 1993, The Journal of cell biology.

[5]  M. Hemler,et al.  Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti- beta 1 antibody , 1993, The Journal of cell biology.

[6]  R. Whitehead,et al.  Retention of tissue‐specific phenotype in a panel of colon carcinoma cell lines: Relationship to correlates , 1992 .

[7]  E. Riboli,et al.  Diet and gastric cancer. A case‐control study in Belgium , 1992, International journal of cancer.

[8]  R. Whitehead,et al.  Patterns of growth and differentiation in the colon carcinoma cell line lim 1863 , 1992, International journal of cancer.

[9]  A. Boyd,et al.  Arg-Gly-Asp-containing peptides expose novel collagen receptors on fibroblasts: implications for wound healing. , 1991, Cell regulation.

[10]  A. Burgess,et al.  The major colonic cell mitogen extractable from colonic mucosa is an N terminally extended form of basic fibroblast growth factor. , 1991, The Journal of biological chemistry.

[11]  H. C. Robinson,et al.  Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies , 1991, International journal of cancer.

[12]  G. Russ,et al.  VLA‐2 is a collagen receptor on endothelial cells , 1991, Immunology and cell biology.

[13]  K. M. Mulder,et al.  Inhibitory Effects of Transforming Growth Factor β1 on Mitogenic Response, Transforming Growth Factor α, and c-myc in Quiescent, Well-Differentiated Colon Carcinoma Cells , 1990 .

[14]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[15]  J. Varani,et al.  Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor β1 and β2 , 1990 .

[16]  R. Cancedda,et al.  Polarized integrin mediates human keratinocyte adhesion to basal lamina. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Liotta,et al.  Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. , 1990, The Journal of biological chemistry.

[18]  M. Schachner,et al.  Expression of J1/tenascin in the crypt-villus unit of adult mouse small intestine: implications for its role in epithelial cell shedding. , 1990, Development.

[19]  L. Shaw,et al.  The activation dependent adhesion of macrophages to laminin involves cytoskeletal anchoring and phosphorylation of the alpha 6 beta 1 integrin , 1990, The Journal of cell biology.

[20]  B. Schwartz,et al.  Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia (review). , 1989, Anticancer research.

[21]  W. Bodmer,et al.  Integrin‐receptor‐mediated differentiation and growth inhibition are enhanced by transforming growth factor‐β in colorectal tumour cells grown in collagen gel , 1989, International journal of cancer.

[22]  B. Rollins,et al.  Environment‐dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor‐beta , 1989, Journal of cellular physiology.

[23]  M. Brattain,et al.  Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. , 1989, Cancer research.

[24]  K. M. Mulder,et al.  Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. , 1989, Experimental cell research.

[25]  V. Quaranta,et al.  A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. , 1989, The EMBO journal.

[26]  J. Massagué,et al.  Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. , 1989, The Journal of biological chemistry.

[27]  H. Kresse,et al.  Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. , 1988, The Journal of biological chemistry.

[28]  P. Bornstein,et al.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Coffey,et al.  Transforming Growth Factor α and β Expression in Human Colon Cancer Lines: Implications for an Autocrine Model , 1987 .

[30]  R. Whitehead,et al.  A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. , 1987, Cancer research.

[31]  R. Juliano,et al.  Expression and function of a putative cell surface receptor for fibronectin in hamster and human cell lines , 1986, The Journal of cell biology.

[32]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[33]  R. Coffey,et al.  Production of transforming growth factors by human colon cancer lines. , 1986, Cancer Research.

[34]  H. Hauri,et al.  Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells , 1985, The Journal of cell biology.

[35]  M. Sporn,et al.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[37]  D. Gospodarowicz,et al.  Are factors originating from serum, plasma, or cultured cells involved in the growth‐promoting effect of the extracellular matrix produced by cultured bovine corneal endothelial cells? , 1983, Journal of cellular physiology.

[38]  V. Hascall,et al.  Effects of 4-methyl umbelliferyl-beta-D-xylopyranoside on chondrogenesis and proteoglycan synthesis in chick limb bud mesenchymal cell cultures. , 1979, The Journal of biological chemistry.

[39]  T. Dexter,et al.  Growth inhibitory effects of transforming growth factor-beta 1 in vivo. , 1991, Growth factors.

[40]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[41]  J. Massagué,et al.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. , 1989, The Journal of biological chemistry.